Jennifer Cane
Senior Research Scientist in Outbreak Pathogens
I am working on projects including the development and evaluation of vaccines for Sudan ebolavirus, and lead the immunogenicity testing in a first-in-human trial of a ChAdOx1 vaccine against Marburg disease.
My previous research has been in the fields of respiratory immunology and microbiology. I joined Prof Teresa Lambe's group in May 2024, translating my experiences to development of vaccines for haemorrhagic fevers.
Recent publications
-
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.
Journal article
Howell I. et al, (2024), J Allergy Clin Immunol
-
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.
Journal article
Cane J. et al, (2024), J Infect, 88
-
Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis
Preprint
Howell I. et al, (2024)
-
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23
Preprint
Cane J. et al, (2023)
-
Additional effects of oral prednisolone following mepolizumab on the nasal transcriptome
Conference paper
Howell I. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62